Aug 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2017 Jun 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 15.97 16.49 68.00
(-3.1 pct) (+12.0 pct) (+4.9 pct)
Operating 597 mln 1.72 5.00
(-65.3 pct) (+67.4 pct) (+10.1 pct)
Recurring 663 mln 1.83 5.00
(-63.8 pct) (+208.1 pct) (+12.7 pct)
Net 657 mln 1.33 3.80
(-50.5 pct) (+49.0 pct) (+7.2 pct)
EPS 12.39 yen 25.01 yen 72.34 yen
Ann Div 32.00 yen 34.00 yen
-Q2 div 16.00 yen 17.00 yen
-Q4 div 16.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))